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Background: Nebulised therapy is commonly used in the management of patients
with asthma and chronic obstructive pulmonary disease (COPD). There are guidelines
setting out standards for maintenance of the compressor and replacement and care
of consumables. This study surveys patients using nebulisers to ascertain the
reported use and maintenance of the nebulisers and any side effects related to
therapy.
Methods: An anonymous postal questionnaire, requesting information on nebuliser
use and maintenance, and side effects was sent to 200 patients who had been
maintained on nebuliser therapy and had been in contact with the nebuliser service
at Glasgow Royal Infirmary within the last year.
Results: One hundred and seventeen (58.5%) questionnaires were returned
completed or partially completed for analysis. The majority of patients who replied
were female (median age of 69 years). The most commonly reported diagnosis was
COPD (87/117); 92/117 (79%) were smokers or ex-smokers. The most commonly
reported side effects associated with treatment are dry mouth, tremor and chest
tightness. The responses to questions on servicing, maintenance and replacement of
consumables indicate that patients comply poorly with these activities. Additionally
compliance with the prescribed drug regimen occurs in less than 50% of the patient
cohort.
Conclusions: The results of this study indicate that compliance with instructions
given on the care and maintenance of home nebulisers may be suboptimal.
Additionally patients reported poorer compliance than was predicted. These areas
may be improved with the introduction of a new patient information leaflet.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Nebulisers are commonly used in the management
of airways disease and are the subject of a British
Thoracic Society (BTS) Guideline.1 The majority of
nebulisers are used for the delivery of beta agonists
and anticholinergic agents and less commonly for
steroids and antiinfective agents. They are used
both in acute situations and in maintenance regi-
mens. Patients with chronic obstructive pulmonary
disease (COPD) are often prescribed both a bronch-
odilator and an anticholinergic agent on a regular
basis while asthmatic patients, using a nebuliser,
may either take their medication as required or on
a regular basis.2,3
For the majority of patients maintained on
nebulised agents at home, a jet nebuliser, which
comprises a nebulising chamber and an electrical
compressor, is used for the delivery of the drugs.
Within the BTS guideline1 for the use of nebulisers
there are some suggestions4 for the maintenance of
the compressor and the replacement of the con-
sumables required for efficient operation of the
nebulisers. These suggest that the compressor
should be serviced annually; at this time the filter
is normally replaced on the compressor. Consum-
ables, mouthpiece, mask and tubing should be
replaced regularly at 3–6 monthly intervals and the
nebuliser chamber should be washed in hot soapy
water, rinsed and left to dry naturally once daily. It
is also suggested that patients should receive an
information leaflet and instruction on how to use
the equipment.
Previous studies on the compliance with therapy
have either optimised the patient’s technique, with
repeated instruction5 or have used electronic
devices to log the use of the nebuliser.6 To our
knowledge this is the first study that relies on
patient reported data and also investigates the
patients cleaning and maintenance of their nebu-
lisers.
The aim of this study was to survey patients who
had received a nebuliser from the respiratory unit
at Glasgow Royal Infirmary to ascertain how they
use and maintain their nebuliser at home and what
if any, side effects relating to their treatment.Methods
Nebulisers are issued to patients from the Depart-
ment of Respiratory Medicine following a review by
a Respiratory Consultant and a 2-week trial of
medication using an appropriate nebuliser device
and compressor system. The correct use of thenebuliser is demonstrated and a medication pre-
scription and written instructions for the routine
care and cleaning of the nebuliser chamber and
compressor system are issued. Before the trial of
treatment, spirometry and a symptom and activity
questionnaire are completed. These are repeated
following the 2-week trial to assess symptomatic
benefit. If there is symptomatic improvement on
the validated questionnaires and the patient has
expressed willingness to continue nebuliser treat-
ment, then a permanent nebuliser is issued. The
patient is given consumables to last a year and is
informed that an appointment for routine main-
tenance and electrical safety check of the equip-
ment will be sent at an appropriate time.
The study was carried out using an anonymous
postal questionnaire. The questionnaire was de-
signed to collect data on a variety of areas of
interest relating to the use of nebulisers by patients
in their homes. The questionnaire was split into
sections on demographics, information about the
nebuliser and its use, side effects related to the
treatments, and the servicing and maintenance of
the nebuliser unit. The questions were all closed
questions and an explanatory letter was included.
The questionnaire was posted to 200 randomly
selected patients who were identified from the
database of patients who had had a nebuliser issued
from the respiratory unit at Glasgow Royal Infirm-
ary and who had been in contact with the service
within the last year. Patients were excluded if their
nebuliser had not been serviced within the last
year. A reply paid envelope was issued but follow-
up of the non-responding patients was not possible
due the anonymity requested by the ethics com-
mittees.
Data from the returned questionnaires were
entered into a secure database. Ten percent of
the data entries were validated for accuracy.
Descriptive statistics were used in the analysis of
data.
The study had ethical approval from the North
Glasgow University NHS Trust Research ethics
committee and the University of Strathclyde ethics
committee. The ethics committee also reviewed
the questionnaire before use.Results
There are currently 682 nebuliser systems on loan
from the Department of Respiratory Medicine to
418 women and 264 men. Of the 200 questionnaires
posted to 130 women and 70 men, 117 (58.5%) were
returned completed or partially completed. There
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(w2 ¼ 0:05; P40:5; DF ¼ 1) between the population
who have nebulisers supplied by the hospital and
those who responded to the questionnaire. The
demographics of the study population are shown in
Table 1.
Patients with self-reported diagnosis of asthma
had been diagnosed a median (IQR) of 17.5 (11–30)Table 1 Demographics of the study population.
Item Number
Male:female 44:73
Age–median (IQR) 69 years (62–75)
Diagnosis
Asthma 19
COPD 87
Bronchiectasis 9
Not answered 2
Smoking history
Current smoker 26
Ex-smoker 66
Non smoker 25
Years smoked–median (IQR) 40 (30–50)
Asthma 30 (17–30)
COPD 42 (30–50)
Source of nebuliser
Hospital 103
General Practitioner 3
Bought by patient 6
Unknown 5
Length of time using a nebuliser (years–median
(IQR))
Overall 4 (2.25–8)
Asthma 9.5 (5–15)
COPD 3.5 (2–7)
Number of consultations (median (IQR))
GP 6 (4–12)
Hospital doctor 3 (1–5)
Table 2 Replacement of disposables.
Frequency Number of patients (%)
Filters Tubing
1–3 months 17 (14.5) 18 (15.3
4–6 months 22 (18.8) 24 (20.5
7–11 months 5 (4.3) 5 (4.3)
Annually 28 (23.9) 26 (22.2
More than 12 months
When damaged 6 (5.1) 8 (6.8)
Never 15 (12.8) 13 (11.1
Not answered 24 (20.5) 23 (19.6years ago while the patients with a self-reported
diagnosis of COPD had been diagnosed 10 (5–10)
years ago. The source and length of time the
patients had used their nebuliser indicate that
the majority were hospital initiated and the
patients with asthma had been using their nebuli-
sers for a longer period of time. Patients app-
eared to consult their GP more often than they
were seen by the secondary care services. When
asked if they followed the advice given 77/114
(67.5%) indicated that they always did. This,
however, was not confirmed by later questions on
the cleaning and replacement of disposables
(Tables 2–4), which indicate poor compliance with
the recommended servicing, cleaning and replace-
ment regimens.
It was also recorded in the respiratory database
that the majority of patients were prescribed their
nebulised solutions four times a day and it was
expected that this would be confirmed in answer to
the question
’ ’
How often do you use your nebuli-
ser?’’ The results in Table 5 suggest that less than
half the patients use their nebuliser in this way,
with the asthmatic patients showing poorer com-
pliance than the patients with COPD. Table 6
indicates the side effects of treatment identified
by the patients.Discussion
The population of patients included in this study
was chosen to reflect the patients who have
recently had their nebuliser serviced and are in
contact with the nebuliser service at Glasgow Royal
Infirmary. These patients reflect the population of
patients who have a home nebuliser supplied by the
hospital but it is appreciated that a number of
patients may have nebulisers supplied by their GP.
It was not possible to access these patients as weChambers Frequency of servicing
) 21 (17.9)
) 18 (15.4) 14 (12.0)
3 (2.6)
) 25 (21.4) 53 (45.3)
6 (5.1)
7 (6.0)
) 21 (17.9) 6 (5.1)
) 22 (18.8) 38 (37.5)
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either been supplied their nebuliser from the
hospital or who have had their nebuliser servicedTable 3 Cleaning of the nebuliser chamber.
Frequency Number of patients (%)
After each use 55 (47.0)
Daily 25 (21.4)
Weekly 18 (15.4)
Monthly 4 (3.4)
Never cleaned 2 (1.7)
Not answered 10 (8.5)
Table 4 Methods of cleaning.
Method of cleaning Number of patients (%)
Warm soapy water,
then rinse
80 (68.4)
Water only 18 (15.4)
Sterilise 14 (12.0)
Dry with a cloth 64 (54.7)
Dry naturally 41 (35.0)
Table 5 Frequency of use.
Number (%)
Frequency Overall Asthma COPD
Not used 2 (1.7) 0 (0) 0 (0)
Less than four
times a day
49 (41.9) 9 (47.4) 35 (40.2)
Four times a day 44 (37.6) 5 (26.3) 37 (42.5)
More than four
times a day
12 (10.2) 3 (15.8) 7 (8.0)
As required 2 (1.7) 1 (5.3) 1 (1.2)
Not answered 8 (6.8) 1 (5.3) 7 (8.0)
Table 6 Side effects.
Number (%)
Once a day Once a week
Tremor 30 (25.6) 10 (8.5)
Chest tightness 30 (25.6) 10 (8.5)
Tachycardia 12 (10.2) 13 (11.1)
Dry eyes 23 (19.6) 7 (6.0)
Headache 19 (16.2) 16 (13.7)
Dry mouth 80 (68.4) 9 (7.7)there. A decision was also made to limit the
potential contacts to patients who had had contact
with the respiratory unit in the last year to avoid
potential distress to relatives of deceased patients
in the event that the respiratory unit had not been
informed of this event.
The results of this questionnaire survey indicate
that there may be some problems with the use and
servicing of home nebuliser systems. While the
patients indicate that they have been informed of
how to use and look after their nebuliser, the
answers to the questions on the servicing and
replacement of disposables indicate that these
replacements may not be undertaken as suggested
or recommended. Particular concern is raised by
the infrequent changes of the tubing and the
chambers and the frequency of cleaning of the
chamber. Patients are supplied with replacement
chambers and tubing when the nebuliser is serviced
annually, and instructed that the chambers should
be washed with warm soapy water, rinsed and left
to dry after each use as recommended in the
current BTS guideline on nebuliser use.1 This
evidence of reported infrequent cleaning is of
concern as it has been reported that nebulisers
that are less frequently cleaned may be a source of
bacterial contamination.7
Patient compliance also appears to be subopti-
mal. The majority of patient who are supplied with
a nebuliser from the hospital are given a prescrip-
tion indicating that the medicines should be used
four times a day. The responses to this question-
naire suggest that most patients do not comply with
this regimen. In the asthmatic population this may
be due to patients not requiring therapy but they
do not indicate a high as required usage. The
reported compliance in patients with COPD of
42.5% lies within the compliance of 57%
(+/34.5%) reported by Corden et al.6
Regarding the side effects experienced by the
patients, almost half of the patients experienced
tremor and 80/98 (81.6%) experienced dry mouthOnce a month Never Not answered
5 (4.3) 18 (15.4) 54 (46.2)
13 (11.1) 14 (12.0) 50 (42.7)
15 (12.8) 19 (16.2) 58 (49.6)
9 (7.7) 18 (15.4) 68 (58.1)
3 (2.6) 21 (17.9) 58 (49.6)
3 (2.6) 6 (5.1) 19 (16.2)
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eyes. This is not entirely unexpected as the
majority of patients were maintained on both
salbutamol and ipratropium solutions.
There are some limitations in the interpretation
of these data. These arise from the use of a postal
questionnaire which was intended to be com-
pleted by the patient. It would have been prefer-
able for respondents to have indicated who
completed the survey. Due to the anonymity of
the questionnaire it was impossible to verify if the
patient or some other third party completed the
questionnaire. Where it was not possible to send
reminders to non-respondents, a reply rate of
nearly 60% is a reasonable outcome for this
study. The number of questionnaires posted was
chosen to achieve at least 100 replies and this was
exceeded.Conclusion
The results of this study indicate poor compliance
with servicing and maintenance of nebulisers.
Better information provision may have a role in
improving compliance. The information gained
from this study on patient behaviour will be used
to facilitate a new patient information leaflet.
Following the launch of this leaflet, a further study
to investigate changes in behaviour and compliance
with therapy is proposed.Acknowledgements
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